Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Exocyst complex component 2 is a protein encoded by the EXOC2 gene in humans. It is a constituent of the exocyst complex, an evolutionarily conserved hetero-octameric protein complex that is essential for the targeting and tethering of exocytic vesicles to specific docking sites at the plasma membrane. The exocyst complex governs critical processes in polarized vesicle trafficking, cell polarity, and membrane expansion in higher eukaryotes. EXOC2 interacts with the actin cytoskeletal remodeling machinery and the Ral subfamily of GTPases, supporting processes like filopodia formation in fibroblasts and exocytosis. Disruption of EXOC2 function is implicated in impaired cell polarity, migration, ciliogenesis, and certain neurodevelopmental and cancer phenotypes; however, it is not a recognized direct therapeutic target at present[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exocyst complex component 2 (EXOC2).